1. Li C, Wang Z, Yang, Y，Jiang Q, Jiang Y, Xiao J,Shen L, Wu W, Li C（通讯作者）. Pro-resolving lipid mediators in diseases: exploring the molecular basis and clinical implication. Mol Biomed 7, 1 (2026). (IF=10.8)
2. Li C, Yang Y, Zhou F, Jiang Q, Jiang Y, Huang X, Zhang Y, Ye Z, Xu G, Kao G, Zhou K, Yang F, Xiao J, Wu W, Li C（通讯作者）. Efferocytosis in Health and Disease. MedComm. 2025;6(12):e70546. (IF=10.8)
3. Yan M, Zhong Y, Ni S, Zhang S, Jiang Y, Zhu L, Zhang K, Cai K, Qu K, Li C（共同通讯）, Wu W. CCR2-Engineered Macrophage Membrane-Coated Metal-Polyphenol Nanozyme to Enhance Antioxidation Activity for Inhibiting the Atherosclerotic Progression. Adv Healthc Mater.2025:e02151. (IF=9.7)
4. Chen X, Wang L, Jiang Y, Tang W, Xiao J, Deng W, Ren X, Li C（通讯作者）. Interplay between triglyceride-glucose index and cardiovascular events in hypertensive patients with controlled blood pressure (SBP<140 mmHg): insights from the SPRINT trial. Front Endocrinol (Lausanne) 2025;16:1508667. (IF=4.6)
5. Jiang Q, Li C, Jiang Y, Ye Z, Xu G, Zhang Y, Yang F, Xiao J, Li C（通讯作者）. BMP10 in Cardiovascular Disease: From Pathogenesis to Therapeutic Strategies. Front Biosci (Landmark Ed). 2025;30(7):31356. (IF=3.1)
6. Zhang Y, Li C, Jiang Q, Jiang Y, Xu G, Kao G, Yang Y, Shen B, Xiao J, Ye Z, Li C（通讯作者）. Unraveling neutrophil extracellular traps: A new frontier in kidney disease therapy. Life Sci.2025;379:123892. (IF=5.1)
7. Chen Q, Yu Y, Zhu L, Duan X, Zhong Y, Li C（共同通讯）, Wu W. Recent progress of carbon dots in the theranostics of cardiovascular and cerebrovascular diseases. Nanoscale. 2025;17(24):14521-14557. (IF=5.1)
8. Zhu L, Zhong Y, Yan M, Ni S, Zhao X, Wu S, Wang G, Zhang K, Chi Q, Qin X, Li C（共同通讯）, Huang X, Wu W. Macrophage Membrane-Encapsulated Dopamine-Modified Poly Cyclodextrin Multifunctional Biomimetic Nanoparticles for Atherosclerosis Therapy. ACS Appl Mater Interfaces. 2024;16(25):32027-32044. (IF=8.2)
9. Mou N, Duan X, Qu K, Chen Q, He Z, Cao Y, Zhang K, Qin X, Zhu L, Han Z, Li C（共同通讯）, Zhong Y, Wu W. Macrophage Membrane Spontaneously Encapsulated Cyclodextrin-Based Nanomedicines for Improving Lipid Metabolism and Inflammation in Atherosclerosis. ACS Appl Mater Interfaces. 2024;16(37):49660-49672. (IF=8.2)
10. Li C, Zhang W, Xiao J, Zeng C, Xu C. The importance of ankel-brachial index in prediction vascular complications in transradial access procedures. Sci Prog. 2024;107(2):368504241261853. (IF=2.9)
11. Zhang W, Li C(共同第一), Xu Y, He B, Hu M, Cao G, Li L, Wu S, Wang X, Zhang C, Zhao J,Xie J, Xu Z, Li Q, Wang G. Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019. Mediat Inflamm. 2021;2021:8812304. (IF=4.53)
12. Zhang W, Wang Y, Li C(共同第一), Xu Y, Wang X, Wu D, Gao Z, Qian H, You Z, Zhang Z, He B, Wang G. Extracellular CIRP-Impaired Rab26 Restrains EPOR-Mediated Macrophage Polarization in Acute Lung Injury. Front Immunol. 2021;12:768435. (IF=8.786)
13. Zhou B, Li C(共同第一), Shou J, Zhang Y, Wen C, Zeng C. The cumulative blood pressure load and target organ damage in patients with essential hypertension. J Clin Hypertens (Greenwich) 2020;22(6):981-990. (IF=3.7)
14. Li C, Hu Z, Zhang W, Yu J, Yang Y, Xu Z, Luo H, Liu X, Liu Y, Chen C, Cai Y, Xia X, Zhang X, Wang DZ, Wu G, Zeng C. Regulation of Cholesterol Homeostasis by a Novel Long Non-coding RNA LASER. Sci Rep. 2019;9(1):7693.(IF=4.0)
15. Zhang W, Zhang Y, Li CW(共同第一), Jones P, Wang C, Fan Y. Effect of Statins on COPD: A Meta-Analysis of Randomized Controlled Trials. Chest. 2017;152(6):1159-1168. (IF=7.7)
16. Li C, Gao M, Zhang W, Chen C, Zhou F, Hu Z, Zeng C. Zonulin Regulates Intestinal Permeability and Facilitates Enteric Bacteria Permeation in Coronary Artery Disease. Sci Rep. 2016;6:29142. (IF=4.3)
17. Li C, Luo X, Zhang W, Zhou L, Wang H, Zeng C. YaAn earthquake increases blood pressure among hospitalized patients. Clin Exp Hypertens. 2016;38(6):495-9. (IF=1.16)
18. Li C, Lin L, Zhang W, Zhou L, Wang H, Luo X, Luo H, Cai Y, Zeng C. Efficiency and safety of proprotein convertase subtilisin/kexin 9 monoclonal antibody on hypercholesterolemia: a meta-analysis of 20 randomized controlled trials. J Am Heart Assoc. 2015;4(6):e001937. (IF=5.1)
19. Li C, Zhang W, Zhou F, Chen C, Zhou L, Li Y, Liu L, Pei F, Luo H, Hu Z, Cai J,Zeng C. Cholesteryl ester transfer protein inhibitors in the treatment of dyslipidemia: a systematic review and meta-analysis. PLoS One. 2013;8(10):e77049. (IF=3.1)
20. Li C, Pei F, Zhu X, Duan DD, Zeng C. Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction. Clin Biochem. 2012;45(10-11):727-32. (IF=2.1)
